Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
Clin Pain. 2018 Dec;17(2):107-110. English. Case Report.
Sohn D , Park GY , Im S , Jeon SH , Choi Y .
Department of Rehabilitation Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea.
Department of Hemato-oncology Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea.
Department of Rehabilitation Medicine, Dongsan Medical Center, College of Medicine, Keimyung University, Daegu, Korea. ymchoi@dsmc.or.kr
Abstract

Objective

For patients who do not relieve with pharmacological intervention, interventional treatment including neurolytic blocks may have a specific role in palliative cancer management.

Method

We performed cervical stellate ganglion block for the second time with Botulinum toxin type A mixed with 4 ml of normal saline, total 75 IU of Botulinum toxin type A, minimal effective dosage was measured to minimize the possible side effects.

Results

About 3 days later, the patient reported that her continuous pain intensity had decreased from 8/10 to 4/10 on the visual analogue scale score. The frequency of the pain attack that required additional morphine injections was also decreased. As a result, her maximum morphine requirement dose per day was significantly reduced.

Conclusion

In this case, cervical stellate ganglion block with Botulinum toxin had longer lasting effect in the continuous pain intensity and resulted in less frequent pain attack. Botulinum toxin can be a possible intervention material in intractable neuropathic pain related to cancer.

Copyright © 2019. Korean Association of Medical Journal Editors.